Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 2/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | RHOA | P61586 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14845574 | 0.87 | TDP1 (0.48) | CYP1A2TDP1RAB9AHTTMEN1 | |
| SCHEMBL13679136 | 0.85 | CYP1A2 (0.43) | CYP1A2TDP1RAB9AHTTMEN1 | |
| SCHEMBL14214100 | 0.85 | CYP1A2 (0.57) | CYP1A2TDP1RAB9AHTTMEN1 | |
| SCHEMBL840342 | 0.85 | TDP1 (0.61) | CYP1A2TDP1RAB9APKMMAPT | |
| SCHEMBL840932 | 0.84 | TDP1 (0.51) | CYP1A2TDP1RAB9AHTTMEN1 | |
| SCHEMBL1450590 | 0.81 | RAB9A (0.44) | CYP1A2RAB9AHTTMEN1KMT2A | |
| SCHEMBL14541678 | 0.80 | MAPT (0.52) | CYP1A2TDP1RAB9AHTTMEN1 | |
| SCHEMBL17742670 | 0.79 | CYP1A2 (0.42) | CYP1A2RAB9AHTTMEN1KMT2A | |
| SCHEMBL840742 | 0.78 | TDP1 (0.50) | CYP1A2TDP1RAB9AMEN1KMT2A | |
| SCHEMBL21713276 | 0.78 | HDAC6 (0.47) | TDP1MEN1KMT2ASMN1; SMN2HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230273361-A1 | OPTICALLY ANISOTROPIC FILM, CIRCULARLY POLARIZING PLATE, AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-08-31 | — | — | US | disclosed |
| US-20100047483-A1 | BIREFRINGENT FILM, LAMINATED FILM, AND IMAGE DISPLAY DEVICE | NITTO DENKO CORPORATION (JP) | 2010-02-25 | — | — | US | disclosed |
| US-20100047483-A1 | BIREFRINGENT FILM, LAMINATED FILM, AND IMAGE DISPLAY DEVICE | NITTO DENKO CORPORATION (JP) | 2010-02-25 | — | — | US | disclosed |
| US-20100047483-A1 | BIREFRINGENT FILM, LAMINATED FILM, AND IMAGE DISPLAY DEVICE | NITTO DENKO CORPORATION (JP) | 2010-02-25 | — | — | US | disclosed |
| EP-1663995-B1 | SULFODERIVATIVES OF ACENAPHTHO [1,2-B]QUINOXALINE, LYOTROPIC LIQUID CRYSTAL AND ANISOTROPIC FILM ON THEIR BASE | NITTO DENKO CORP (JP) | 2007-09-05 | — | — | EP | disclosed |
| EP-1663995-A1 | SULFODERIVATIVES OF ACENAPHTHO [1,2-B]QUINOXALINE, LYOTROPIC LIQUID CRYSTAL AND ANISOTROPIC FILM ON THEIR BASE | NITTO DENKO CORPORATION (JP) | 2006-06-07 | — | — | EP | disclosed |
| US-7045177-B2 | Concurrent applying, molecular orientation; dissolving in solvent; applying to substrate; drying | NITTO DENKO CORPORATION (JP) | 2006-05-16 | — | — | US | disclosed |
| WO-2005051926-A1 | SULFODERIVATIVES OF ACENAPHTHO[1,2-B]QUINOXALINE, LYOTROPIC LIQUID CRYSTAL AND ANISOTROPIC FILM ON THEIR BASE | NITTO DENKO CORPORATION (JP) | 2005-06-09 | — | — | WO | disclosed |
| US-20050109986-A1 | Concurrent applying, molecular orientation; dissolving in solvent; applying to substrate; drying | INSOLVENCY SERVICES GROUP, INC. | 2005-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050109986-A1 | Concurrent applying, molecular orientation; dissolving in solvent; applying to substrate; drying | CFH, CCNH, HCN3 | CYP1A2 1504/4885TDP1 4162/4885RAB9A 1721/4885 |
| US-20100047483-A1 | BIREFRINGENT FILM, LAMINATED FILM, AND IMAGE DISPLAY DEVICE | CFH, C1R, AQP3 | CYP1A2 1179/4885TDP1 4652/4885RAB9A 1834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.